Oncotelic Therapeutics Price on July 21, 2023
OTLCDelisted Stock | USD 0.02 0 6.38% |
If you're considering investing in Oncotelic OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Oncotelic Therapeutics stands at 0.02, as last reported on the 29th of November, with the highest price reaching 0.02 and the lowest price hitting 0.02 during the day. We have found twenty-four technical indicators for Oncotelic Therapeutics, which you can use to evaluate the volatility of the company. Please check Oncotelic Therapeutics' Coefficient Of Variation of (5,652), variance of 203.7, and insignificant Risk Adjusted Performance to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
Oncotelic OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Oncotelic |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
OTLC |
Based on monthly moving average Oncotelic Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncotelic Therapeutics by adding Oncotelic Therapeutics to a well-diversified portfolio.
Oncotelic Therapeutics Valuation on July 21, 2023
It is possible to determine the worth of Oncotelic Therapeutics on a given historical date. On July 21, 2023 Oncotelic was worth 0.02 at the beginning of the trading date compared to the closed value of 0.02. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oncotelic Therapeutics otc stock. Still, in general, we apply an absolute valuation method to find Oncotelic Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oncotelic Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oncotelic Therapeutics' related companies.
Open | High | Low | Close | Volume | |
0.02 | 0.02 | 0.02 | 0.02 | 153,400 | |
07/21/2023 | 0.02 | 0.02 | 0.02 | 0.02 | 20,100 |
0.02 | 0.02 | 0.02 | 0.02 | 42,885 |
Backtest Oncotelic Therapeutics | | | Oncotelic Therapeutics History | | | Oncotelic Therapeutics Valuation | Previous | Next |
Oncotelic Therapeutics Trading Date Momentum on July 21, 2023
On July 24 2023 Oncotelic Therapeutics was traded for 0.02 at the closing time. The top price for the day was 0.02 and the lowest listed price was 0.02 . The trading volume for the day was 42.9 K. The trading history from July 24, 2023 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 10.00% . The trading delta at closing time against the current closing price is 17.50% . |
Oncotelic Therapeutics Fundamentals Correlations and Trends
By evaluating Oncotelic Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oncotelic Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oncotelic financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Oncotelic Therapeutics OTC Stock history
Oncotelic Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oncotelic is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oncotelic Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oncotelic Therapeutics stock prices may prove useful in developing a viable investing in Oncotelic Therapeutics
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. It also develops OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes and CA4P for the treatment of advanced metastatic melanoma. Oncotelic Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 16 people.
Oncotelic Therapeutics OTC Stock Technical Analysis
Oncotelic Therapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Oncotelic Therapeutics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Oncotelic Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Oncotelic Therapeutics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Oncotelic Therapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncotelic Therapeutics shares will generate the highest return on investment. By undertsting and applying Oncotelic Therapeutics otc stock market strength indicators, traders can identify Oncotelic Therapeutics entry and exit signals to maximize returns
Oncotelic Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Oncotelic Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Oncotelic OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oncotelic to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0) | |||
Jensen Alpha | (0.43) | |||
Total Risk Alpha | (2.41) | |||
Treynor Ratio | (0.18) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Oncotelic OTC Stock
If you are still planning to invest in Oncotelic Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncotelic Therapeutics' history and understand the potential risks before investing.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |